Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Non-Current Debt (2012 - 2026)

Updated

Adma Biologics (ADMA) recorded Non-Current Debt of $192.84 million in Q2 2026, up 162.7% from $73.4 million a year earlier but down 0.4% from the prior quarter.

Analysis

Adma Biologics (ADMA) Non-Current Debt (2012 - 2026) Analysis & Trends

At the end of FY2025, Adma Biologics reported Non-Current Debt of $69.33 million, down 4.2% from FY2024.

  • Annual Non-Current Debt has declined for three straight years, with a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
  • Across earlier years, Non-Current Debt came in at $72.34 million in FY2024 (-44.6%), $130.59 million in FY2023 (-8.6%), $142.83 million in FY2022 (+50.6%) and $94.87 million in FY2021 (+2.0%).
  • Quarterly Non-Current Debt has ranged from $69.33 million in Q4 2025 to $193.58 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Non-Current Debt rose in two of the last eight quarters, with growth averaging 16.6%.
  • Peak year-over-year performance for Non-Current Debt in the last five years was growth of 166.9% in Q1 2026, against a decline of 44.6% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $193.58 million (Q1 2026), $69.33 million (Q4 2025) and $70.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 192.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.84 Mn
Mar 31, 2026 193.58 Mn
Dec 31, 2025 69.33 Mn
Sep 30, 2025 70.08 Mn
Jun 30, 2025 73.40 Mn
Mar 31, 2025 72.53 Mn
Dec 31, 2024 72.34 Mn
Sep 30, 2024 101.33 Mn
Jun 30, 2024 131.07 Mn
Mar 31, 2024 130.85 Mn
Dec 31, 2023 130.59 Mn
Sep 30, 2023 142.03 Mn
Jun 30, 2023 140.31 Mn
Mar 31, 2023 144.30 Mn
Dec 31, 2022 142.83 Mn
Sep 30, 2022 141.37 Mn
Jun 30, 2022 139.81 Mn
Mar 31, 2022 138.42 Mn
Dec 31, 2021 94.87 Mn
Sep 30, 2021 94.36 Mn
API Access

Adma Biologics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ADMA&period=max&api_key=YOUR_API_KEY